These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Potential of Cannabidiol for Acute Respiratory Distress Syndrome in COVID-19. Azimi S; Saghafi F; Mohammadi MH; Moghimi MH; Akhavan SA; Khataminia M; Shirvani M; Sohrevardi SM; Jamialahmadi T; Sahebnasagh A; Sahebkar A Curr Pharm Des; 2023; 29(29):2291-2296. PubMed ID: 37818584 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro. Suryavanshi SV; Zaiachuk M; Pryimak N; Kovalchuk I; Kovalchuk O Cells; 2022 Apr; 11(9):. PubMed ID: 35563697 [TBL] [Abstract][Full Text] [Related]
5. Cannabidiol Suppresses Cytokine Storm and Protects Against Cardiac and Renal Injury Associated with Sepsis. Maayah ZH; Ferdaoussi M; Alam A; Takahara S; Silver H; Soni S; Martens MD; Eurich DT; Dyck JRB Cannabis Cannabinoid Res; 2024 Feb; 9(1):160-173. PubMed ID: 36594988 [No Abstract] [Full Text] [Related]
6. Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome. Rossi M; Piagnerelli M; Van Meerhaeghe A; Zouaoui Boudjeltia K Med Hypotheses; 2020 Nov; 144():110242. PubMed ID: 33254548 [TBL] [Abstract][Full Text] [Related]
7. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression. Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332 [TBL] [Abstract][Full Text] [Related]
8. A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome. Khodadadi H; Salles ÉL; Shin E; Jarrahi A; Costigliola V; Kumar P; Yu JC; Morgan JC; Hess DC; Vaibhav K; Dhandapani KM; Baban B J Cannabis Res; 2021 Oct; 3(1):45. PubMed ID: 34598736 [TBL] [Abstract][Full Text] [Related]
9. Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019. Nagarkatti P; Miranda K; Nagarkatti M Front Pharmacol; 2020; 11():589438. PubMed ID: 33240092 [TBL] [Abstract][Full Text] [Related]
10. Dehydrozingerone ameliorates Lipopolysaccharide induced acute respiratory distress syndrome by inhibiting cytokine storm, oxidative stress via modulating the MAPK/NF-κB pathway. Tirunavalli SK; Gourishetti K; Kotipalli RSS; Kuncha M; Kathirvel M; Kaur R; Jerald MK; Sistla R; Andugulapati SB Phytomedicine; 2021 Nov; 92():153729. PubMed ID: 34517257 [TBL] [Abstract][Full Text] [Related]
11. Fighting the storm: could novel anti-TNFα and anti-IL-6 Kovalchuk A; Wang B; Li D; Rodriguez-Juarez R; Ilnytskyy S; Kovalchuk I; Kovalchuk O Aging (Albany NY); 2021 Jan; 13(2):1571-1590. PubMed ID: 33465050 [TBL] [Abstract][Full Text] [Related]
12. High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs. Aswad M; Hamza H; Pechkovsky A; Zikrach A; Popov T; Zohar Y; Shahar E; Louria-Hayon I Front Immunol; 2022; 13():875546. PubMed ID: 35651623 [TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction and angiogenesis: what is missing from COVID-19 and cannabidiol story? Ashtar Nakhaei N; Najarian A; Farzaei MH; Norooznezhad AH J Cannabis Res; 2022 Apr; 4(1):21. PubMed ID: 35414120 [TBL] [Abstract][Full Text] [Related]
14. Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm. Morgulchik N; Athanasopoulou F; Chu E; Lam Y; Kamaly N Interface Focus; 2022 Feb; 12(1):20210006. PubMed ID: 34956607 [TBL] [Abstract][Full Text] [Related]
15. How could perfluorocarbon affect cytokine storm and angiogenesis in coronavirus disease 2019 (COVID-19): role of hypoxia-inducible factor 1α. Moasefi N; Fouladi M; Norooznezhad AH; Yarani R; Rahmani A; Mansouri K Inflamm Res; 2021 Jul; 70(7):749-752. PubMed ID: 34173853 [TBL] [Abstract][Full Text] [Related]
17. Specialized pro-resolving lipid mediators regulate inflammatory macrophages: A paradigm shift from antibiotics to immunotherapy for mitigating COVID-19 pandemic. Kumar V; Yasmeen N; Chaudhary AA; Alawam AS; Al-Zharani M; Suliman Basher N; Harikrishnan S; Goud MD; Pandey A; Lakhawat SS; Sharma PK Front Mol Biosci; 2023; 10():1104577. PubMed ID: 36825200 [TBL] [Abstract][Full Text] [Related]
18. The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the "cytokine storm" in COVID-19 patients: a hypothesis. Thomas G; Frederick E; Hausburg M; Goldberg L; Hoke M; Roshon M; Mains C; Bar-Or D Patient Saf Surg; 2020; 14():21. PubMed ID: 32431755 [TBL] [Abstract][Full Text] [Related]